Infectious Diseases and Therapy Q1 Unclaimed

Infectious Diseases and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, dedicated to the publication of high-quality clinical, observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions, including devices, across all areas of infectious diseases. The key features of the journal are:Rapid publication: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online.Open access: All articles published open access (CC BY-NC).Inclusivity: All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience.Personal service: The journal’s team will re-format articles and upload submissions on behalf of authors, if necessary.Digital Features and Plain Language Summaries: These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see “Author Information – Guidelines for digital features and plain language summaries” under “Submission guidelines”).Publication fees: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5500/$6850/£4700. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. If you would like to request a discount or waiver please do so either ahead of submission or at the very start of the submission process. Requests made after this stage will not be considered.Contact: For more information about the journal, including pre-submission enquiries, please contact Hannah Payne at hannah.payne@springer.com.   Publishing research on infectious disease therapies and interventionsRapid publication and personal point of contact throughoutMaximum visibility with open access It has an SJR impact factor of 1,351.

Categories: Infectious Diseases (Q1) Microbiology (medical) (Q1)

Price

2750 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA